Palomino Laboratories (PALX) Accounts Payables (2022 - 2025)

Palomino Laboratories recorded quarterly Accounts Payables of $55687.0 in Q4 2025, down 8.64% quarter-over-quarter from $60952.0 in Q3 2025, and up 1592.1% year-over-year from $3291.0 in Q4 2024.

Palomino Laboratories' Accounts Payables history runs 4 years deep, the most recent figure standing at $55687.0 for Q4 2025.

  • In Q4 2025, Accounts Payables rose 1592.1% year-over-year to $55687.0; the TTM figure through Dec 2025 stood at $55687.0 (up 1592.1% YoY), while the FY2025 annual figure was $55687.0, up 1592.1% from the prior year.
  • Accounts Payables came in at $55687.0 for Q4 2025 at Palomino Laboratories, down from $60952.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $60952.0 in Q3 2025 to a low of $58.0 in Q4 2023.
  • A 4-year average of $35037.1 and a median of $43954.0 in 2024 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables tumbled 99.54% in 2023 and surged 5574.14% in 2024, its largest moves.
  • Palomino Laboratories' Accounts Payables stood at $12500.0 in 2022, then sank by 99.54% to $58.0 in 2023, then soared by 5574.14% to $3291.0 in 2024, then soared by 1592.1% to $55687.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods registered $55687.0, $60952.0, and $40781.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 55,687.00
Sep 30, 2025 60,952.00
Jun 30, 2025 40,781.00
Mar 31, 2025 45,816.00
Dec 31, 2024 3,291.00
Sep 30, 2024 46,757.00
Jun 30, 2024 43,954.00
Mar 31, 2024 47,112.00
Dec 31, 2023 58.00
Sep 30, 2023 28,500.00
Dec 31, 2022 12,500.00